Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model
- PMID: 12907804
- DOI: 10.1126/science.1086137
Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model
Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive, lethal neuromuscular disease that is associated with the degeneration of spinal and brainstem motor neurons, leading to atrophy of limb, axial, and respiratory muscles. The cause of ALS is unknown, and there is no effective therapy. Neurotrophic factors are candidates for therapeutic evaluation in ALS. Although chronic delivery of molecules to the central nervous system has proven difficult, we recently discovered that adeno-associated virus can be retrogradely transported efficiently from muscle to motor neurons of the spinal cord. We report that insulin-like growth factor 1 prolongs life and delays disease progression, even when delivered at the time of overt disease symptoms.
Similar articles
-
Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.J Neurosci. 2002 Aug 15;22(16):6920-8. doi: 10.1523/JNEUROSCI.22-16-06920.2002. J Neurosci. 2002. PMID: 12177190 Free PMC article.
-
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.Nature. 2004 May 27;429(6990):413-7. doi: 10.1038/nature02544. Nature. 2004. PMID: 15164063
-
Systemic administration of scAAV9-IGF1 extends survival in SOD1G93A ALS mice via inhibiting p38 MAPK and the JNK-mediated apoptosis pathway.Brain Res Bull. 2018 May;139:203-210. doi: 10.1016/j.brainresbull.2018.02.015. Epub 2018 Feb 27. Brain Res Bull. 2018. PMID: 29499331
-
Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases.Hum Gene Ther. 2000 Nov 20;11(17):2315-29. doi: 10.1089/104303400750038435. Hum Gene Ther. 2000. PMID: 11096437 Review.
-
Current developments in gene therapy for amyotrophic lateral sclerosis.Expert Opin Biol Ther. 2015 Jul;15(7):935-47. doi: 10.1517/14712598.2015.1044894. Epub 2015 May 10. Expert Opin Biol Ther. 2015. PMID: 25959569 Review.
Cited by
-
Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis.Mol Ther. 2013 Aug;21(8):1486-96. doi: 10.1038/mt.2013.115. Epub 2013 Jun 4. Mol Ther. 2013. PMID: 23732987 Free PMC article.
-
Routes of administration for adeno-associated viruses carrying gene therapies for brain diseases.Front Mol Neurosci. 2022 Oct 26;15:988914. doi: 10.3389/fnmol.2022.988914. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36385771 Free PMC article. Review.
-
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents.Drugs. 2022 Sep;82(13):1367-1388. doi: 10.1007/s40265-022-01769-1. Epub 2022 Sep 19. Drugs. 2022. PMID: 36121612 Review.
-
Insulin-Like Growth Factor 2 As a Possible Neuroprotective Agent and Memory Enhancer-Its Comparative Expression, Processing and Signaling in Mammalian CNS.Int J Mol Sci. 2021 Feb 12;22(4):1849. doi: 10.3390/ijms22041849. Int J Mol Sci. 2021. PMID: 33673334 Free PMC article. Review.
-
AAV2 mediated retrograde transduction of corticospinal motor neurons reveals initial and selective apical dendrite degeneration in ALS.Neurobiol Dis. 2012 Aug;47(2):174-83. doi: 10.1016/j.nbd.2012.03.036. Epub 2012 Apr 11. Neurobiol Dis. 2012. PMID: 22521461 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
